Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged fischer 344 rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 2, 1997, Pages 760-768

  Hebert, Meleik A ^a   Gerhardt, Greg A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DEXAMPHETAMINE; DOPAMINE RECEPTOR; HOMOVANILLIC ACID; NEUROTROPHIC FACTOR; POTASSIUM;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; EXTRACELLULAR SPACE; GLIA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; MICRODIALYSIS; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; NUCLEUS ACCUMBENS; RATS; RATS, INBRED F344; SUBSTANTIA NIGRA;

EID: 0030854870     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. 3H]GBR-12935 in human putamen. Neurobiol. Aging 10: 661-664, 1989.
2. ALTAR, C. A. AND MARSHALL, J. F.: Neostriatal dopamine uptake and reversal of age-related movement disorders with dopamine-uptake inhibitors. Ann. NY Acad. Sci. 515: 343-354, 1988.
3. ARBUTHNOTT, G. W., FAIRBROTHER, I. S. AND BUTCHER, S. P.: Dopamine release and metabolism in the rat striatum: An analysis by in vivo brain microdialysis. Pharmacol. Ther. 48: 281-293, 1990.
4. ARENAS, E., TRUPP, M., AKERUD, P. AND IBANEZ, C. F.: GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15: 1465-1473, 1995.
5. BARK, I. C. AND WILSON, M. C.: Regulated vesicular fusion in neurons: Snapping together to details. Proc. Natl. Acad. Sci. U.S.A. 91: 4621-4624, 1994.
6. BECK, K. D., IRWIN, I., VALVERDE, J., BRENNAN, T. J., LANGSTON, J. W. AND HEFTI, F.: GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron 16: 665-673, 1996.
7. BENNETT, D. A., BECKETT, L. A., MURRAY, A. M., SHANNON, K. M., GOETZ, C. G., PILGRIM, D. M. AND EVANS, D. A.: Prevalence of parkinsonian signs and associated mortality in a community population of older people. N. Engl. J. Med. 334: 71-76, 1996.
8. BIRREN, J. E., WOODS, A. M. AND WILLIAMS, M. V.: Speed of behavior as an indicator of age changes and the integrity of the nervous system. In Brain Function and Old Age, ed. by F. Hoffmeister and C. Muller, Springer, New York, 1979.
9. BOWENKAMP, K. E., HOFFMAN, A. F., GERHARDT, G. A., HENRY, M. A., BIDDLE, P. T., HOFFER, B. J. AND GRANHOLM, A. C.: Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355: 479-489, 1995.
10. BOWENKAMP, K. E., LAPCHAK, P. A., HOFFER, B. J. AND BICKFORD, P. C.: Glial cell line-derived neurotrophic factor reverses motor impairment in 16-17 month old rats. Neurosci. Lett. 211: 81-84, 1996.
11. BURWELL, R. D., LAWLER, C. P. AND GALLAGHER, M.: Mesostriatal dopamine markers in aged Long-Evans rats with sensorimotor impairment. Neurobiol. Aging 16: 175-186, 1995.
12. CARLSSON, A. AND WINBLAD, B.: Influence of age and time interval between death and autopsy on dopamine and beta-methoxytyramine levels in human basal ganglia. J. Neural Transm. Gen. Sec. 38: 271-276, 1976.
13. CHESSELET, M. F.: Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis [Review]. Neuroscience 12: 347-375, 1984.
14. CHURCH, W. H. AND JUSTICE, J. B., JR.: Rapid sampling and determination of extracellular dopamine in vivo. Anal. Chem. 59: 712-716, 1987.
15. DLUZEN, D. E., MCDERMOTT, J. L. AND RAMIREZ, V. D.: Changes in dopamine release in vitro from the corpus striatum of young versus aged rats as a function of infusion modes of L-dopa, potassium, and amphetamine. Exp. Neurol. 112: 153-160, 1991.
16. DUNNETT, S. B. AND ROBBINS, T. W.: The functional role of mesotelencephalic dopamine systems [Review]. Biol. Rev. Camb. Philos. Soc. 67: 491-518, 1992.
17. EMERICH, D. F., MCDERMOTT, P., KRUEGER, P., BANKS, M., ZHAO, J., MARSZALKOWSKI, J., FRYDEL, B., WINN, S. R. AND SANBERG, P. R.: Locomotion of aged rats: relationship to neurochemical but not morphological changes in nigrostriatal dopaminergic neurons. Brain Res. Bull. 32: 477-486, 1993.
18. EMERICH, D. F., PLONE, M., FRANCIS, J., FRYDEL, B. R., WINN, S. R. AND LINDNER, M. D.: Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts. Brain Res. 736: 99-110, 1996.
19. FRIEDEMANN, M. N.: In vivo electrochemical studies of dopamine diffusion and clearance in the striatum of young and aged Fischer-344 rats. Age 15: 23-28, 1992.
20. FRIEDEMANN, M. N. AND GERHARDT, G. A.: Regional effects of aging on dopaminergic function in the Fischer-344 rat. Neurobiol. Aging 13: 325-332, 1992.
21. GAGE, F. H., DUNNETT, S. B. AND BJORKLUND, A.: Spatial learning and motor deficits in aged rats. Neurobiol. Aging 5: 43-48, 1984.
22. GASH, D. M., ZHANG, Z., OVADIA, A., CASS, W. A., YI, A., SIMMERMAN, L., RUSSELL, D., MARTIN, D., LAPCHAK, P. A., COLLINS, F., HOFFER, B. J. AND GERHARDT, G. A.: Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380: 252-255, 1996.
23. GERHARDT, G. A., CASS, W. A., HENSON, M., ZHANG, Z., OVADIA, A., HOFFER, B. J. AND GASH, D. M.: Age-related changes in potassium-evoked overflow of dopamine in the striatum of the rhesus monkey. Neurobiol. Aging 16: 939-946, 1995.
24. GILLIS, K. D., MOSSNER, R. AND NEHER, E.: Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules. Neuron 16: 1209-1220, 1996.
25. GOVONI, S., LODDO, P., SPANO, P. F. AND TRABUCCHI, M.: Dopamine receptor sensitivity in brain and retina of rats during aging. Brain Res. 138: 565-570, 1977.
26. GOVONI, S., MEMO, M., SAIANI, L., SPANO, P. F. AND TRABUCCHI, M.: Impairment of brain neurotransmitter receptors in aged rats. Mech. Ageing Dev. 12: 39-46, 1980.
27. HALL, M., HOFFER, B. AND GERHARDT, G.: Rapid and sensitive determination of catecholamines in small tissue samples by high pressure liquid chromatography coupled with dual-electrode coulometric electrochemical detection. LC-GC 7: 258-265, 1989.
28. HEBERT, M. A., VAN HORNE, C. G., HOFFER, B. J. AND GERHARDT, G. A.: Functional effects of GDNF in normal rat striatum: Presynaptic studies using in vivo electrochemistry and microdialysis. J. Pharmacol. Exp. Ther. 279: 1181-1190, 1996.
29. HEFTI, F.: Neurotrophic factor therapy for nervous system degenerative diseases [Review]. J. Neurobiol. 25: 1418-1435, 1994.
30. HOFFER, B. J., HOFFMAN, A., BOWENKAMP, K., HUETTL, P., HUDSON, J., MARTIN, D., LIN, L. F. AND GERHARDT, G. A.: Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182: 107-111, 1994.
31. HORNYKIEWICZ, O., KISH, S. J. AND RAJPUT, A. H.: Neurochemical aspects of Parkinson's disease and the dementing brain disorders: relation to brain aging. In Basic and Clinical Therapeutic Aspects of Alzheimer's and Parkinson's Disease, ed. by T. Nagatsu, A. Fisher and M. Yshida, pp. 445-452, Plenum, New York, NY, 1990.
32. HUDSON, J., GRANHOLM, A. C., GERHARDT, G. A., HENRY, M. A., HOFFMAN, A., BIDDLE, P., LEELA, N. S., MACKERLOVA, L., LILE, J. D., COLLINS, F. AND ET AL.: Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36: 425-432, 1995.
33. INGRAM, D. K.: Motor performance variability during aging in rodents. Assessment of reliability and validity of individual differences. Ann. NY Acad. Sci. 515: 70-96, 1988.
34. JIAO, S. S., MILLER, P. J. AND LAPCHAK, P. A.: Chronic intraventricular glial cell line-derived neurotrophic factor (GDNF) increases dopaminergic and cholinergic markers in aged F344 rats (Abstract). Soc. Neurosci. Abstr. 26: 1966, 1996.
35. JING., S.; WEN, D., YU, Y., HOLST, P. L., Luo, Y., FANG, M., TAMIR, R., ANTONIO, L., HU, Z., CUPPLES, R., LOUIS, J. C., HU, S., ALTROCK, B. W. AND FOX, G. M.: GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNF R-alpha, a novel receptor for GDNF. Cell 85: 1113-1124, 1996.
36. JOSEPH, J. A., BARTUS, R. T., CLODY, D., MORGAN, D., FINCH, C., BEER, B. AND SESACK, S.: Psychomotor performance in the senescent rodent: reduction of deficits via striatal dopamine receptor up-regulation. Neurobiol. Aging 4: 313-319, 1983.
37. JOSEPH, J. A., BERGER, R. E., ENGEL, B. T. AND ROTH, G. S.: Age-related changes in the nigrostriatum: a behavioral and biochemical analysis. J. Gerontol. 33: 643-649, 1978.
38. +-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence. Brain Res. 454: 140-148, 1988.
39. JOSEPH, J. A. AND ROTH, G. S.: Upregulation of striatal dopamine receptors and improvement of motor performance in senescence [Review]. Ann. NY Acad. Sci. 515: 355-362, 1988.
40. JUSTICE, J. B., JR., NICOLAYSEN, L. C. AND MICHAEL, A. C.: Modeling the dopaminergic nerve terminal. J. Neurosci. Methods 22: 239-252, 1988.
41. KEARNS, C. M. AND GASH, D. M.: GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672: 104-111, 1995.
42. KISH, S. J., SHANNAK, K., RAJPUT, A., DECK, J. H. AND HORNYKIEWICZ, O.: Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. J. Neurochem. 58: 642-648, 1992.
43. KNIPPER, M., LEUNG, L. S., ZHAO, D. AND RYLETT, R. J.: Short-term modulation of glutamatergic synapses in adult rat hippocampus by NGF. Neuroreport 5: 2433-2436, 1994.
44. LIN, L. F., DOHERTY, D. H., LILE, J. D., BEKTESH, S. AND COLLINS, F.: GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons [see comments]. Science 260: 1130-1132, 1993.
45. LIN, L. F., ZHANG, T. J., COLLINS, F. AND ARMES, L. G.: Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63: 758-768, 1994.
46. LINDSAY, R. M., ALTAR, C. A., CEDARBAUM, J. M., HYMAN, C. AND WIEGAND, S. J.: The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease [Review]. Exp. Neurol. 124: 103-118, 1993.
47. LINDSAY, R. M.: Neuron saving schemes. Nature 373: 289-290, 1995.
48. MARSHALL, J. F. AND ALTAR, C. A.: Striatal dopamine uptake and swim performance of the aged rat. Brain Res. 379: 112-117, 1986.
49. MARSHALL, J. F. AND BERRIOS, N.: Movement disorders of aged rats: reversal by dopamine receptor stimulation. Science 206: 477-479, 1979.
50. MARTIN, J. R., FUCHS, A. AND HARTIG, J.: Spontaneous activity in the senescent rat (Abstract). Neurosci. Lett. Suppl. 14: 236, 1983.
51. MCGEER, P. L., MCGEER, E. G. AND SUZUKI, J. S.: Aging and extrapyramidal function. Arch. Neurol. 34: 33-35, 1977.
52. MCINTOSH, H. H. AND WESTFALL, T. C.: Influence of aging on catecholamine levels, accumulation, and release in F-344 rats. Neurobiol. Aging 8: 233-239, 1987.
53. MISSALE, C., GOVONI, S., PASINETTI, G., ASSINI, C., SPANO, P. F., BATTAINI, F. AND TRABUCCHI, M.: Age-dependent changes in the mechanisms regulating dopamine uptake in the central nervous system. J. Gerontol. 41: 136-139, 1986.
54. MORGAN, D. G. AND FINCH, C. E.: Dopaminergic changes in the basal ganglia. A generalized phenomenon of aging in mammals. Ann. NY Acad. Sci. 515: 145-160, 1988.
55. MORTIMER, J. A.: Human motor behavior and aging. Ann. NY Acad. Sci. 515: 54-66, 1988.
56. OLSON, L.: Neurotrophins in neurodegenerative disease: theoretical issues and clinical trials [Review]. Neurochem. Int. 25: 1-3, 1994.
57. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
58. RICHARDS, M., STERN, Y., MARDER, K., COTE, L. AND MAYEUX, R.: Relationships between extrapyramidal signs and cognitive function in a community-dwelling cohort of patients with Parkinson's disease and normal elderly individuals. Ann. Neurol. 33: 267-274, 1993.
59. ROBINSON, T. E. AND WHISHAW, I. Q.: Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res. 450: 209-224, 1988.
60. ROSE, G. M., GERHARDT, G. A., CONBOY, G. L. AND HOFFER, B. J.: Age-related alterations in monoamine release from rat striatum: an in vivo electrochemical study. Neurobiol. Aging 7: 77-82, 1986.
61. ROSENMUND, C. AND STEVENS, C. F.: Definition of the readily releasable pool of vesicles at hippocampal synapses. Neuron 16: 1197-1207, 1996.
62. SABEL, B. A. AND STEIN, D. G.: Extensive loss of subcortical neurons in the aging rat brain. Exp. Neurol. 73: 507-516, 1981.
63. SANBERG, P. R., HENAULT, M. A., HAGENMEYER-HOUSER, S. H. AND RUSSELL, K. H.: The topography of amphetamine and scopolamine-induced hyperactivity: toward an activity print. Behav. Neurosci. 101: 131-133, 1987.
64. SEVERSON, J. A., MARCUSSON, J., WINBLAD, B. AND FINCH, C. E.: Age-correlated loss of dopaminergic binding sites in human basal ganglia. J. Neurochem. 39: 1623-1631, 1982.
65. SHIMIZU, N., DUAN, S. M., HORI, T. AND OOMURA, Y.: Glutamate modulates dopamine release in the striatum as measured by brain microdialysis. Brain Res. Bull. 25: 99-102, 1990.
66. STEVENS, C. F. AND TSUJIMOTO, T.: Estimates for the pool size of releasable quanta at a single central synapse and for the time required to refill the pool. Proc. Natl. Acad. Sci. U.S.A. 92: 846-849, 1995.
67. SUDARSKY, L. AND RONTHAL, M.: Gait disorders among elderly patients. A survey study of 50 patients. Arch. Neurol. 40: 740-743, 1983.
68. TAKAHASHI, M., ASAI, N., IWASHITA, T., ISOMURA, T., MIYAZAKI, K. AND MATSUYAMA, M.: Characterization of the ret proto-oncogene products expressed in mouse L cells. Oncogene 8: 2925-2929, 1993.
69. TOMAC, A., LINDQVIST, E., LIN, L. F., OGREN, S. O., YOUNG, D., HOFFER, B. J. AND OLSON, L.: Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo [see comments]. Nature 373: 335-339, 1995.
70. TREANOR, J. J., GOODMAN, L., DE SAUVAGE, F., STONE, D. M., POULSEN, K. T., BECK, C. D., GRAY, C., ARMANINI, M. P., POLLOCK, R. A., HEFTI, F., PHILLIPS, H. S., GODDARD, A., MOORE, M. W., BUJ-BELLO, A., DAVIES, A. M., ASAI, N., TAKAHASHI, M., VANDLEN, R., HENDERSON, C. E. AND ROSENTHAL, A.: Characterization of a multicomponent receptor for GDNF [see comments]. Nature 382: 80-83, 1996.
71. TRUPP, M., ARENAS, E., FAINZILBER, M., NILSSON, A. S., SIEBER, B. A., GRIGORIOU, M., KILKENNY, C., SALAZAR-GRUESO, E., PACHNIS, V., ARUMAE, U., SARIOLA, H., SAARMA, M. AND IBANEZ, C. F.: Functional receptor for GDNF encoded by the c-ret proto-oncogene [see comments]. Nature 381: 785-788, 1996.
72. TRUSSELL, L. O. AND FISCHBACH, G. D.: Glutamate receptor desensitization and its role in synaptic transmission. Neuron 3: 209-218, 1989.
73. WALLACE, J. E., KRAUTER, E. E. AND CAMPBELL, B. A.: Motor and reflexive behavior in the aging rat. J. Gerontol. 35: 364-370, 1980.
74. WATANABE, H.: Differential decrease in the rate of dopamine synthesis in several dopaminergic neurons of aged rat brain [Review]. Exp. Gerontol. 22: 17-25, 1987.
75. WELFORD, A. T.: Motor skills and aging. In The Aging Motor System, ed. by J. A. Mortimer, F. J. Pirozzolo and T. Nagatsu, pp. 152-187, Praeger, New York, 1982.
76. WELFORD, A. T., NORRIS, A. H. AND SHOCK, N. W.: Speed and accuracy of movement and their changes with age. Acta Psychol. 30: 3-15, 1969.
77. WILLIG, F., PALACIOS, A., MONMAUR, P., M'HARZI, M., LAURENT, J. AND DELACOUR, J.: Short-term memory, exploration and locomotor activity in aged rats. Neurobiol. Aging 8: 393-402, 1987.
78. WU, M., BRUDZYNSKI, S. M. AND MOGENSON, G. J.: Functional interaction of dopamine and glutamate in the nucleus accumbens in the regulation of locomotion. Can. J. Physiol. Pharmacol. 71: 407-413, 1993.
79. ZELNIK, N., ANGEL, I., PAUL, S. M. AND KLEINMAN, J. E.: Decreased density of human striatal dopamine uptake sites with age. Eur. J. Pharmacol. 126: 175-176, 1986.